← Back to Patent Explorer
US4744787A Expired / Lapsed US ⏱️ 0.0 years remaining

Iontophoresis apparatus and methods of producing same

Assignee: MEDTRNIC Inc
•
Filing: 1984-10-29
•
Granted: 1988-05-17
•
Expires: 2004-10-29
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Improved iontophoresis drug delivery apparatus or device wherein one or more electrochemically active components are employed or "sacrificed" so as to minimize the hydrolysis of water during drug delivery. Efficiency of drug delivery is increased and pH changes in the device or adjacent the patient's skin are minimized.

Inventors

  • 👤 Joseph B. Phipps
  • 👤 Darrel F. Untereker

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 13:25
CPC Classifications
A; A61; A61N; A61N1/00; A61N1/02; A61N1/04; A61N1/0404; A61N1/0408; A61N1/0428; A61N1/0448; A61N1/0432; A61N1/0436; A61N1/0444

Claims Analysis

Total Claims: 16
Claim 1
Independent Claim 84 words
An improved electrode for an iontophoresis device, the electrode comprising: a source of drug to be iontophoretically delivered; support means for said drug source; at least one electrochemically active component in electrical connection to said drug source which, during iontophoretic drug delivery, hydrolyzes water to a minimal extent; wherein said electrically active component is a current distribution member; and wherein the current distribution member comprises an intercalation compound and the balancing ion of the drug in the drug source is an alkali metal ion.
Claim 2
Dependent Claim 84 words
An improved electrode for an iontophoresis device, the electrode comprising: a source of drug to be iontophoretically delivered; support means for said drug source; at least one electrochemically active component in electrical connection to said drug source which, during iontophoretic drug delivery, hydrolyzes water to a minimal extent; wherein said electrically active component is a current distribution member; and wherein the current distribution member comprises an intercalation compound and the balancing ion of the drug in the drug source is an alkali metal ion.
Claim 3
Dependent Claim 94 words
An improved electrode for an iontophoresis device, the electrode comprising: a source of drug to be iontophoretically delivered; support means for said drug source; at least one electrochemically active component in electrical connection to said drug source which, during iontophoretic drug delivery, hydrolyzes water to a minimal extent; wherein said electrochemically active component is a current distribution member; and wherein the current distribution member comprises an amalgam selected from the group consisting of lead, mercury or mercury/cadmium amalgams and the balancing ion of the drug in the drug source is an alkali metal ion.
Claim 4
Dependent Claim 94 words
An improved electrode for an iontophoresis device, the electrode comprising: a source of drug to be iontophoretically delivered; support means for said drug source; at least one electrochemically active component in electrical connection to said drug source which, during iontophoretic drug delivery, hydrolyzes water to a minimal extent; wherein said electrochemically active component is a current distribution member; and wherein the current distribution member comprises an amalgam selected from the group consisting of lead, mercury or mercury/cadmium amalgams and the balancing ion of the drug in the drug source is an alkali metal ion.
Claim 5
Dependent Claim 84 words
An iontophoresis device having an improved electrode, the electrode comprising: a source of drug to be iontophoretically delivered; support means for said drug source; at least one electrochemically active component in electrical connection with said drug source which, during iontophoretic drug delivery, hydrolyzes water to a minimal extent; wherein said electrochemically active component is a current distribution member; and wherein the current distribution member comprises an intercalation compound and the balancing ion of the drug dispersed in the drug source is an alkali ion.
Claim 6
Dependent Claim 84 words
An iontophoresis device having an improved electrode, the electrode comprising: a source of drug to be iontophoretically delivered; support means for said drug source; at least one electrochemically active component in electrical connection with said drug source which, during iontophoretic drug delivery, hydrolyzes water to a minimal extent; wherein said electrochemically active component is a current distribution member; and wherein the current distribution member comprises an intercalation compound and the balancing ion of the drug dispersed in the drug source is an alkali ion.
Claim 7
Dependent Claim 94 words
An iontophoresis device having an improved electrode, the electrode comprising: a source of drug to be iontophoretically delivered; support means for said drug source; at least one electrochemically active component in electrical connection with said drug source which, during iontophoretic drug delivery, hydrolyzes water to a minimal extent; wherein said electrochemically active component is a current distribution member; and wherein the current distribution member comprises an amalgam selected from the group consisting of lead, mercury or mercury/cadmium amalgams, and the balancing ion of the drug in the drug source is an alkali metal ion.
Claim 8
Dependent Claim 94 words
An iontophoresis device having an improved electrode, the electrode comprising: a source of drug to be iontophoretically delivered; support means for said drug source; at least one electrochemically active component in electrical connection with said drug source which, during iontophoretic drug delivery, hydrolyzes water to a minimal extent; wherein said electrochemically active component is a current distribution member; and wherein the current distribution member comprises an amalgam selected from the group consisting of lead, mercury or mercury/cadmium amalgams, and the balancing ion of the drug in the drug source is an alkali metal ion.
Claim 9
Dependent Claim 81 words
An iontophoresis device having an improved electrode, the electrode comprising: a source of drug to be iontophoretically delivered; support means for said drug source; at least one electrochemically active component in electrical connection with said drug source which, during iontophoretic drug delivery, hydrolyzes water to a minimal extent; wherein said drug source is a gel having the drug to be delivered therein; and wherein the electrochemically active component comprises silver and the drug dispersed in the drug source comprises propranolol hydrochloride.
Claim 10
Dependent Claim 81 words
An iontophoresis device having an improved electrode, the electrode comprising: a source of drug to be iontophoretically delivered; support means for said drug source; at least one electrochemically active component in electrical connection with said drug source which, during iontophoretic drug delivery, hydrolyzes water to a minimal extent; wherein said drug source is a gel having the drug to be delivered therein; and wherein the electrochemically active component comprises silver and the drug dispersed in the drug source comprises propranolol hydrochloride.
Claim 11
Independent Claim 166 words
A method for making an improved iontophoretic drug delivery device of the type comprising an anode, a cathode, a source of electrical energy in electrical connection with said anode and cathode at least one of said anode or said cathode having in electrical association therewith a reservoir containing therein a supply of at least one species which is to be iontophoretically delivered, the method comprising the steps of: constructing at least one electrode of the device to include a component which is electrochemically active during iontophoretic drug delivery to produce first species which is capable of interacting with a second species intentionally employed in or generated during operation of the device to produce a product which is not sufficiently influenced by electrical fields to be iontophoretically introduced; providing the aforementioned second species or a precursor thereto to the iontophoretic drug delivery device; and wherein said anode includes a current distribution member comprising silver, and the medicament comprises propranolol present in the form of a chloride salt.
Claim 12
Independent Claim 166 words
A method for making an improved iontophoretic drug delivery device of the type comprising an anode, a cathode, a source of electrical energy in electrical connection with said anode and cathode at least one of said anode or said cathode having in electrical association therewith a reservoir containing therein a supply of at least one species which is to be iontophoretically delivered, the method comprising the steps of: constructing at least one electrode of the device to include a component which is electrochemically active during iontophoretic drug delivery to produce first species which is capable of interacting with a second species intentionally employed in or generated during operation of the device to produce a product which is not sufficiently influenced by electrical fields to be iontophoretically introduced; providing the aforementioned second species or a precursor thereto to the iontophoretic drug delivery device; and wherein said anode includes a current distribution member comprising silver, and the medicament comprises propranolol present in the form of a chloride salt.
Claim 13
Independent Claim 162 words
A method for making an improved iontophoretic drug delivery device of the type comprising an anode, a cathode, a source of electrical energy in electrical connection with said anode and cathode, at least one of said anode or said cathode having an electrical association therewith a reservoir containing therein a supply of at least one species which is to be iontophoretically delivered, the method comprising the steps of: constructing at least one electrode of the device to include a component which is electrochemically active during iontophoretic drug delivery to produce a first species which is capable of interacting with a second species intentionally employed in or generated during operation of the device to produce a product which is not sufficiently influenced by electrical fields to be iontophoretically introduced; providing the aforementioned second species or a precursor thereto to the iontophoretic drug delivery device; and wherein the cathode is constructed from materials selected from the group consisting of lead, mercury or mercury/cadmium amalgams.
Claim 14
Independent Claim 162 words
A method for making an improved iontophoretic drug delivery device of the type comprising an anode, a cathode, a source of electrical energy in electrical connection with said anode and cathode, at least one of said anode or said cathode having an electrical association therewith a reservoir containing therein a supply of at least one species which is to be iontophoretically delivered, the method comprising the steps of: constructing at least one electrode of the device to include a component which is electrochemically active during iontophoretic drug delivery to produce a first species which is capable of interacting with a second species intentionally employed in or generated during operation of the device to produce a product which is not sufficiently influenced by electrical fields to be iontophoretically introduced; providing the aforementioned second species or a precursor thereto to the iontophoretic drug delivery device; and wherein the cathode is constructed from materials selected from the group consisting of lead, mercury or mercury/cadmium amalgams.
Claim 15
Independent Claim 170 words
A method for making an improved iontophoretic drug delivery device of the type comprising an anode, a cathode, a source of electrical energy in electrical connection with said anode and cathode, at least one of said anode or said cathode having in electrical association therewith a reservoir containing therein a supply of at least one species which is to be iontophoretically delivered, the method comprising the steps of: constructing at least one electrode of the device to include a component which is electrochemically active during iontophoretic drug delivery to produce a first species which is capable of interacting with a second species intentionally employed in or generated during operation of the device to produce a product which is not sufficiently influenced by electrical fields to be iontophoretically introduced; providing the aforementioned second species or a precursor thereto to the iontophoretic drug delivery device; and wherein the cathode is constructed from an intercalation compound selected from the group consisting of sodium tungstate, sodium vanadate (NaV 6 O 13 ) or graphite.
Claim 16
Independent Claim 170 words
A method for making an improved iontophoretic drug delivery device of the type comprising an anode, a cathode, a source of electrical energy in electrical connection with said anode and cathode, at least one of said anode or said cathode having in electrical association therewith a reservoir containing therein a supply of at least one species which is to be iontophoretically delivered, the method comprising the steps of: constructing at least one electrode of the device to include a component which is electrochemically active during iontophoretic drug delivery to produce a first species which is capable of interacting with a second species intentionally employed in or generated during operation of the device to produce a product which is not sufficiently influenced by electrical fields to be iontophoretically introduced; providing the aforementioned second species or a precursor thereto to the iontophoretic drug delivery device; and wherein the cathode is constructed from an intercalation compound selected from the group consisting of sodium tungstate, sodium vanadate (NaV 6 O 13 ) or graphite.

References Cited (Backward Citations)

US3964477A Cited
US4250878A Cited
US4522211A Cited
US4383529A Cited
US4474570A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1991-05-17 1991-11-16 1992-05-17 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1995-05-17 1995-11-16 1996-05-17 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1999-05-17 1999-11-16 2000-05-17 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag